| (210) | Number of the EPO application | 18797408 |
| (220) | Filing date of the EPO application | 2018.10.17 |
| (80) | EPO patent specification publication (B) | EPB nr. 39/2021, 2021.09.29 |
| (110) | EPO patent number | 3697789 |
| (11) | Number of the document | MD 3697789 T2 |
| (21) | Number of the application | e 2020 0857 |
| (71) | Name(s) of applicant(s), code of the country | INCYTE CORPORATION, US; |
| (72) | Name(s) of inventor(s), code of the country | DOUTY Brent, US;
BUESKING Andrew W., US;
BURNS David M., US;
COMBS Andrew P., US;
FALAHATPISHEH Nikoo, US;
JALLURI Ravi Kumar, US;
LEVY Daniel, US;
POLAM Padmaja, US;
SHAO Lixin, US;
SHEPARD Stacey, US;
SHVARTSBART Artem, US;
SPARKS Richard B., US;
YUE Eddy W., US; |
| (73) | Name(s) of owner(s), code of the country | INCYTE CORPORATION, US; |
| (54) | Title of the invention | Condensed imidazole derivatives substituted by tertiary hydroxy groups as pi3k-gamma inhibitors |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 487/04 (2006.01.01); A61P 25/28 (2006.01.01); A61P 35/00 (2006.01.01); A61K 31/4985 (2006.01.01); A61K 31/495 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.09.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.02.28 |
| (30) | Priority | 201762574057 P, 2017.10.18, US; 201762608897 P, 2017.12.21, US; 201862727316 P, 2018.09.05, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2018/056311, 2018.10.17 |
| (87) | International publication | WO 2019/079469, 2019.04.25 |